Blood News and Research

RSS

New nanoparticle-based immunotherapy delays hormone therapy resistance in prostate cancer

A new form of immunotherapy using innovative nanoparticles can delay resistance to hormone therapy and help men with prostate cancer live longer.

5 Aug 2024

Breakthrough study identifies mechanisms behind glucocorticoid resistance in pediatric B-ALL

Josep Carreras Leukaemia Research Institute B-ALL is the most common paediatric cancer and, over the years and thanks to a very effective treatment based on glucocorticoids, its 5-year survival rates have reached 85% and beyond.

5 Aug 2024

State-level insulin cost caps ineffective in increasing insulin use among diabetes patients

In a first-of-its-kind study, a cohort of researchers, led by the University of Colorado Anschutz Medical Campus, evaluated the effects of state-level insulin out-of-pocket costs across states and payers and over time.

5 Aug 2024

Research highlights need for gender-specific diagnosis of heart failure in type 2 diabetes patients

A MedUni Vienna study has investigated gender-specific differences in the diagnosis of systolic heart failure in patients with type 2 diabetes.

5 Aug 2024

Cholesterol imbalance linked to neurodegeneration, study suggests potential strategies for intervention

Research highlights how cholesterol imbalances in the brain contribute to neurodegenerative diseases like Alzheimer's, Huntington's, and Parkinson's, suggesting targeted therapeutic interventions.

5 Aug 2024

Active immune cells discovered in brain's cranial bone marrow fighting glioblastomas

A study uncovers the presence and activity of immune cells in glioblastoma, revealing new insights into brain tumor immunology and potential treatment avenues.

4 Aug 2024

Study confirms cardiovascular safety of COVID-19 vaccines among millions of adults in England

A study confirms the cardiovascular safety of different COVID-19 vaccine doses, showing reduced risks of common cardiovascular events among vaccinated adults in England.

4 Aug 2024

Exploring long COVID: Insights into prevalence, pathophysiology, and treatment

In a new review paper, researchers from the Universities of Arizona, Oxford and Leeds analyzed dozens of previous studies into long COVID to examine the number and range of people affected, the underlying mechanisms of disease, the many symptoms that patients develop, and current and future treatments.

2 Aug 2024

Groundbreaking discovery reveals novel macrophages crucial for lung repair after viral infection

Researchers at the University of Liège (Belgium) have discovered a new population of macrophages, important innate immune cells that populate the lungs after injury caused by respiratory viruses.

2 Aug 2024

Vanderbilt researchers illuminate white matter signals in the spinal cord

Injuries, infection and inflammatory diseases that damage the spinal cord can lead to intractable pain and disability. Some degree of recovery may be possible. The question is, how best to stimulate the regrowth and healing of damaged nerves.

2 Aug 2024

Decreasing folate intake can support healthier metabolisms in aging animal models

In a study published in Life Science Alliance, Texas A&M AgriLife Research scientists found that decreasing folate intake can support healthier metabolisms in aging animal models, challenging the conventional belief that high folate consumption universally benefits health.

2 Aug 2024

Mast cells found to capture and employ neutrophils during allergic reactions

Known for their role in allergic reactions, mast cells have long been recognised as key players in our immune system.

2 Aug 2024

Public insurance recipients less likely to receive diabetes and obesity drug, study reveals

A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with private insurance.

2 Aug 2024

FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma.

2 Aug 2024

New study links obesity to bacterium Megamonas

A recent study published in Cell Host & Microbe identifies a potential obesity-linked bacterium, Megamonas, from a large-scale cohort of obese individuals in China.

2 Aug 2024

Using advanced CRISPR to boost efficiency of CAR-T cell therapies

CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the USA and a year later in Europe for treating acute lymphoblastic leukemia (ALL).

2 Aug 2024

New research reveals keto diet’s impact on cholesterol and gut microbiome

A study from the University of Bath reveals that ketogenic low-carbohydrate diets can increase cholesterol levels and reduce beneficial gut bacteria, specifically Bifidobacterium.

2 Aug 2024

Urgent care or ER? With ‘one-stop shop,’ hospitals offer both under same roof

Facing an ultracompetitive market in one of the nation's fastest-growing cities, UF Health is trying a new way to attract patients: a combination emergency room and urgent care center.

2 Aug 2024

New frontiers in organ regeneration with 3D bioprinting

In a latest review published in Engineering, an international team of scientists from China and the United States has presented a comprehensive analysis of the latest advancements in 3D organ bioprinting. This innovative technology holds the potential to revolutionize regenerative medicine and tackle some of the most pressing issues in organ transplantation.

2 Aug 2024

Uncovering hidden drug benefits through protein mapping

Fewer side effects, improved chances of healing: the goal of precision medicine is to provide patients with the most individualized treatment possible. This requires a precise understanding of what is happening at the cellular level. For the first time, researchers at the Technical University of Munich (TUM) have now succeeded in mapping the interactions of 144 active substances with around 8,000 proteins. The results could help to identify previously unknown potential benefits of existing drugs.

2 Aug 2024

Blood News and Research

New nanoparticle-based immunotherapy delays hormone therapy resistance in prostate cancer

Breakthrough study identifies mechanisms behind glucocorticoid resistance in pediatric B-ALL

State-level insulin cost caps ineffective in increasing insulin use among diabetes patients

Research highlights need for gender-specific diagnosis of heart failure in type 2 diabetes patients

Cholesterol imbalance linked to neurodegeneration, study suggests potential strategies for intervention

Active immune cells discovered in brain's cranial bone marrow fighting glioblastomas

Study confirms cardiovascular safety of COVID-19 vaccines among millions of adults in England

Exploring long COVID: Insights into prevalence, pathophysiology, and treatment

Groundbreaking discovery reveals novel macrophages crucial for lung repair after viral infection

Vanderbilt researchers illuminate white matter signals in the spinal cord

Decreasing folate intake can support healthier metabolisms in aging animal models

Mast cells found to capture and employ neutrophils during allergic reactions

Public insurance recipients less likely to receive diabetes and obesity drug, study reveals

FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

New study links obesity to bacterium Megamonas

Using advanced CRISPR to boost efficiency of CAR-T cell therapies

New research reveals keto diet’s impact on cholesterol and gut microbiome

Urgent care or ER? With ‘one-stop shop,’ hospitals offer both under same roof

New frontiers in organ regeneration with 3D bioprinting

Uncovering hidden drug benefits through protein mapping

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News